NASDAQ · Consumer discretionary

Park Ha Biological Technology Co., Ltd. (BYAH)

Park Ha Biological Technology Co., Ltd. reported revenue of $2.5M in fiscal 2025, up 6.0% from a year earlier. It posted a net loss of $24.4M. In fiscal 2025 capital spending exceeded operating cash flow by $3K. At October 31, 2025 it held $3.8M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer, amended) (20-F/A) filed on May 15, 2026.

Revenue (FY2025)

$2.5M

+6.0% year on year

Net margin

-965.0%

What Park Ha Biological Technology Co., Ltd. does

Park Ha Biological Technology Co., Ltd. is registered with the SEC under industry code SIC 2840 (Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics). Its shares trade on NASDAQ under the ticker BYAH.

Revenue and profit by year

Revenue

Net income

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal year	Revenue	Operating income	Net income	Diluted EPS	Free cash flow
2025	$2.5M	-$24.1M	-$24.4M	-$41.38	-$3K
2024	$2.4M	$793.7K	$478.6K	$0.96	$874.9K
2024	$2.5M	$1.2M	$852K	$1.70	$103.9K
2022	$1.9M	$197K	$191.3K	$0.57	$1.4M

Full financial statements: income, balance sheet and cash flow

Where BYAH ranks in Consumer discretionary

Revenue$2.5M

#923 of 955 in Consumer discretionary · Bottom 3%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Consumer discretionary

Latest SEC filings

What Park Ha Biological Technology Co., Ltd. has filed recently, newest first. Each links to the original document on SEC EDGAR.

September 11, 2026
Foreign issuer update 6-K
September 2, 2026
Foreign issuer update 6-K
August 13, 2026
Passive stake (5% or more) SCHEDULE 13G
August 10, 2026
Passive stake (5% or more) SCHEDULE 13G
August 10, 2026
Passive stake (5% or more) SCHEDULE 13G
August 10, 2026
Passive stake (5% or more) SCHEDULE 13G
August 10, 2026
Passive stake (5% or more) SCHEDULE 13G
August 10, 2026
Passive stake (5% or more) SCHEDULE 13G
August 10, 2026
Passive stake (5% or more) SCHEDULE 13G
August 10, 2026
Passive stake (5% or more) SCHEDULE 13G

Recent insider filings (Forms 3, 4 and 144): 8, the latest on August 10, 2026. Insider transactions on SEC

Insider trades

What the people running Park Ha Biological Technology Co., Ltd. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider bought or sold shares on the open market in the last 90 days. The 1 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.

Bought (open market)

last 90 days

Sold

last 90 days

Date	Insider	What	Shares	Price	Value	Filing
August 3, 2026	Zhu XiaoyanCFO	Received as pay	112,500	$0.18	$20.3K	Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns BYAH

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Holder	Of class	Shares	Filed
Corin Global Partners Holdings Limited13G, passive with 1 related filers	9.8%	422,500	August 10, 2026
Fusen Advertising Design Limited13G, passive with 1 related filers	9.8%	422,500	August 10, 2026
Peverel Summit Holdings Limited13G, passive with 1 related filers	9.8%	422,500	August 10, 2026
Rove Trading Co., Limited13G, passive with 1 related filers	9.8%	422,500	August 10, 2026
Velociti Group Limited13G, passive with 1 related filers	9.8%	422,500	August 10, 2026
Motovance Holdings Limited13G, passive with 1 related filers	9.7%	422,500	August 13, 2026
Nexera Technology Company Limited13G, passive with 1 related filers	9.1%	390,000	August 10, 2026
Pinnacle International Holding Limited13G, passive with 1 related filers	7.6%	325,000	August 10, 2026

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

1 insiders reported holding 112,500 shares in total, about $311.6K at the last price.

Holder	Shares	As of
Zhu XiaoyanCFO	112,500	August 3, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about BYAH

What does Park Ha Biological Technology Co., Ltd. do?

Is Park Ha Biological Technology Co., Ltd. profitable?

No. In fiscal 2025 it reported a net loss of $24.4M on revenue of $2.5M.

How much revenue does Park Ha Biological Technology Co., Ltd. make?

In fiscal 2025 Park Ha Biological Technology Co., Ltd. reported revenue of $2.5M. That is 6.0% more than a year earlier.

When did Park Ha Biological Technology Co., Ltd. last report?

Its most recent periodic report is the annual report (foreign issuer, amended) (20-F/A) filed on May 15, 2026. It covers the period to October 31, 2025. Its newest filing of any kind is the foreign issuer update from September 11, 2026.

Similar companies

Church & Dwight Co Inc

SCL

Stepan Co

WNW

Meiwu Technology Co Ltd

Compare BYAH with

Compare BYAH with any company

Follow BYAH

Get an email when Park Ha Biological Technology Co., Ltd. files with the SEC: results, executive changes, material agreements and annual reports.

Follow BYAH: get an email when it files

Where the numbers come from

Financial figures are the values Park Ha Biological Technology Co., Ltd. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.